Cart
sales@molnova.com
TTNPB
CAS No. 71441-28-6
TTNPB( TTNPB | Ro 13-7410 | Ro-13-7410 | Arotinoid acid )
Catalog No. M17576 CAS No. 71441-28-6
TTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 30 | Get Quote |
|
| 5MG | 47 | Get Quote |
|
| 10MG | 71 | Get Quote |
|
| 25MG | 149 | Get Quote |
|
| 50MG | 291 | Get Quote |
|
| 100MG | 439 | Get Quote |
|
| 500MG | 954 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameTTNPB
-
NoteResearch use only, not for human use.
-
Brief DescriptionTTNPB, a potent RAR agonist, inhibits binding of [3H]tRA of human RARα (IC50: 5.1 nM), β (IC50: 4.5 nM), and γ (IC50: 9.3 nM), respectively.
-
DescriptionTTNPB is a selective and highly potent agonist of retinoic acid receptors (RAR) α, β, and γ.
-
In Vitro——
-
In Vivo——
-
SynonymsTTNPB | Ro 13-7410 | Ro-13-7410 | Arotinoid acid
-
PathwayEndocrinology/Hormones
-
TargetAChR
-
RecptorRARα| RARβ| RARγ| RARγ
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number71441-28-6
-
Formula Weight348.48
-
Molecular FormulaC24H28O2
-
Purity>98% (HPLC)
-
SolubilityDMSO : 11.25 mg/mL. 32.28 mM;
-
SMILESc12c(C(CCC2(C)C)(C)C)ccc(c1)/C(=C/c1ccc(cc1)C(=O)O)/C
-
Chemical Name4-[(E)-2-(5,5,8,8-Tetramethyl-6,7-dihydronaphthalen-2-yl)prop-1-enyl]benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pignatello MA, et al. Toxicol Appl Pharmacol. 1997, 142(2), 319-327.
molnova catalog
related products
-
E7820
E7820 is an angiogenesis inhibitor by suppressing integrin a2 (a cell adhesion molecule expressed on endothelial cells).
-
Tacrine hydrochlorid...
A cholinesterase inhibitor that crosses the blood-brain barrier.
-
Catestatin
Non-competitive nicotinic cholinergic antagonist; selectively inhibits nicotinic-stimulated catecholamine secretion from chromaffin cells and noradrenergic neurons (IC50 ~ 200 nM). Blocks nicotinic-induced cationic signaling (IC50 ~ 200 - 250 nM) and inhibits nicotinic-agonist induced desensitization of catecholamine release. Also stimulates mast cell release of histamine via a separate mechanism.
